Subjects who have received or plan to receive the treatment of benign lesions and T1 and T2 malignant tumors in oropharynx, hypopharynx and larynx with the SP single-port robot.
Conditions
Interventions
Case series:None
Sponsors
Ruijin Hainan Hospital Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age: = 18, regardless of male or female; 2. Patients have received or plan to receive the treatment of benign lesions and T1 and T2 malignant tumors in oropharynx, hypopharynx and larynx with the SP single-port robot; 3. Patients who voluntarily decide to participate in the study and sign the ICF (or exempt from signature of the ICF as approved by the EC).
Exclusion criteria
Exclusion criteria: 1. Subjects having any contraindications of single-port robot surgery; 2. Patients with missing data on the primary endpoint in retrospective cases; 3. The intraoperative anatomy determined that minimally invasive surgery was not suitable; 4. Patients who are considered inappropriate to participate in this study by investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative conversion rate;: The incidence of device-related or likely related complications of Clavien-Dindo classification grade III or higher at postoperative 30 days; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative bleeding volume;The rate of intraoperative blood transfusion;Surgical duration;Length of stay (LOS);Admission to ICU and ICU LOS;Pathologically confirmed positive surgical margin;Postoperative pain score;Short-term recovery of functions; | — |
Countries
China
Contacts
Public ContactMingliang Xiang
Ruijin Hainan Hospital Shanghai Jiao Tong University School of Medicine
Outcome results
None listed